Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tempest Therapeutics
Biotech
Tempest strikes all-stock deal for Factor’s CAR-T pipeline, CEO
After seeking strategic alternatives, Tempest is inking an all-stock transaction for four of Factor's CAR-T candidates.
Gabrielle Masson
Nov 19, 2025 12:22pm
Tempest lays off 80% of workforce to ride out cash crunch
Apr 21, 2025 8:20am
Tempest, amid cash drought, hunts for liver cancer drug partner
Apr 10, 2025 7:24am
Tempest's triplet shows boost over Roche combo in liver cancer
Oct 11, 2023 11:00am
